New light therapy combo shows promise for tough bile duct cancer
NCT ID NCT07398339
First seen Feb 12, 2026 · Last updated May 01, 2026 · Updated 12 times
Summary
This study is for people with advanced bile duct cancer that has caused a blockage. It tests a new approach: a light-activated drug (sodium porphyrin) given with standard chemotherapy. The goal is to see if this combination can help patients live longer and control the disease better. About 30 participants will receive this treatment in an open-label, phase 2 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCERS (BTC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 266, Trumpet Vine Road
RECRUITINGShanghai, Pudong New Area, 200120, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.